{"title":"The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness.","authors":"Neeraj Kumar, Sanjeev Kumar, Abhyuday Kumar, Divendu Bhushan, Amarjeet Kumar, Ajeet Kumar, Veena Singh, Prabhat K Singh","doi":"10.5005/jp-journals-10071-24000","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the cardiovascular system at many levels. It initially infects endothelial cells, inducing marked endothelial damage and inflammation. However, there was no empirical evidence of functional compromise of arterial walls.</p><p><strong>Aims and objective: </strong>Our primary objective was to study functional arterial damage in coronavirus disease 2019 (COVID-19) and establish the noninvasive measurement of arterial stiffness as an independent marker of disease severity.</p><p><strong>Materials and methods: </strong>We recorded the arterial stiffness of 23 mild, 21 moderate, and 20 severe COVID-19 patients grouped on the latest National Institute of Health (NIH) severity criteria. We observed arterial stiffness of COVID-19 patients with standard parameters like noninvasive estimated carotid-femoral pulse wave velocity (cfPWV), age-normalized increase in cfPWV (ANI_cfPWV), age-normalized increase in aortic augmentation pressure (ANI_AugP), and heart rate-normalized augmentation index (HRN_ AIx). All the parameters were also corrected for statistically significant confounding factors.</p><p><strong>Results: </strong>Moderate and severe COVID-19 patients have extremely significantly elevated arterial stiffness than mild patients. In mild patients, cfPWV (829.1 ± 139.2 cm/second) was significantly lower than both moderate (1067 ± 152.5 cm/second, <i>p</i> <0.0001) and severe (1416 ± 253.9 cm/second, <i>p</i> <0.0001) patients. ANI_cfPWV in moderate and severe patients was significantly higher than mild patients (mild: 101.2 ± 126.1 cm/second; moderate: 279 ± 114.4 cm/second; severe: 580.1 ± 216.4 cm/second; intergroup <i>p</i> <0.0001). The results even after correction for significant confounding factors did not show any considerable change in the increasing trend of arterial stiffness.</p><p><strong>Conclusion: </strong>This study establishes the functional deterioration of arteries in proportion to the severity of COVID-19.</p><p><strong>How to cite this article: </strong>Kumar N, Kumar S, Kumar A, Bhushan D, Kumar A, Kumar A, <i>et al.</i> The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness. Indian J Crit Care Med 2021;25(10):1113-1119.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"1113-1119"},"PeriodicalIF":1.5000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/1b/ijccm-25-1113.PMC8645816.pdf","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10071-24000","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13
Abstract
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the cardiovascular system at many levels. It initially infects endothelial cells, inducing marked endothelial damage and inflammation. However, there was no empirical evidence of functional compromise of arterial walls.
Aims and objective: Our primary objective was to study functional arterial damage in coronavirus disease 2019 (COVID-19) and establish the noninvasive measurement of arterial stiffness as an independent marker of disease severity.
Materials and methods: We recorded the arterial stiffness of 23 mild, 21 moderate, and 20 severe COVID-19 patients grouped on the latest National Institute of Health (NIH) severity criteria. We observed arterial stiffness of COVID-19 patients with standard parameters like noninvasive estimated carotid-femoral pulse wave velocity (cfPWV), age-normalized increase in cfPWV (ANI_cfPWV), age-normalized increase in aortic augmentation pressure (ANI_AugP), and heart rate-normalized augmentation index (HRN_ AIx). All the parameters were also corrected for statistically significant confounding factors.
Results: Moderate and severe COVID-19 patients have extremely significantly elevated arterial stiffness than mild patients. In mild patients, cfPWV (829.1 ± 139.2 cm/second) was significantly lower than both moderate (1067 ± 152.5 cm/second, p <0.0001) and severe (1416 ± 253.9 cm/second, p <0.0001) patients. ANI_cfPWV in moderate and severe patients was significantly higher than mild patients (mild: 101.2 ± 126.1 cm/second; moderate: 279 ± 114.4 cm/second; severe: 580.1 ± 216.4 cm/second; intergroup p <0.0001). The results even after correction for significant confounding factors did not show any considerable change in the increasing trend of arterial stiffness.
Conclusion: This study establishes the functional deterioration of arteries in proportion to the severity of COVID-19.
How to cite this article: Kumar N, Kumar S, Kumar A, Bhushan D, Kumar A, Kumar A, et al. The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness. Indian J Crit Care Med 2021;25(10):1113-1119.
背景:严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)感染对心血管系统的影响是多方面的。它最初感染内皮细胞,引起明显的内皮损伤和炎症。然而,没有经验证据表明动脉壁功能受损。目的和目的:我们的主要目的是研究冠状病毒病2019 (COVID-19)的功能性动脉损伤,并建立动脉硬度的无创测量作为疾病严重程度的独立标志。材料和方法:我们记录了23例轻度、21例中度和20例重度COVID-19患者的动脉僵硬度,这些患者按照美国国立卫生研究院(NIH)最新的严重程度标准分组。我们用无创估计颈-股脉波速度(cfPWV)、cfPWV的年龄归一化升高(ANI_cfPWV)、主动脉增压压(ANI_AugP)的年龄归一化升高、心率归一化增强指数(HRN_ AIx)等标准参数观察COVID-19患者的动脉硬度。所有参数也对统计上显著的混杂因素进行了校正。结果:中、重度COVID-19患者动脉僵硬度明显高于轻度患者。在轻度患者中,cfPWV(829.1±139.2 cm/s)显著低于中度患者(1067±152.5 cm/s), p p p p。结论:本研究确定了动脉功能恶化与COVID-19严重程度成比例。如何引用本文:Kumar N, Kumar S, Kumar A, Bhushan D, Kumar A, Kumar A,等。COSEVAST研究结果:COVID-19严重程度与动脉僵硬度激增成正比的证据。中华检验医学杂志;2011;25(10):1113-1119。